Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05837039 · ClinicalTrials.gov registry record
A Comparison of Healthcare Provider and Caregiver Perception of Discomfort in Advanced Cancer Patients Who Have a Hypoactive Delirium
A clinical trial of Hypoactive Delirium, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05837039: Recruiting study of Hypoactive Delirium, sponsored by M.D. Anderson Cancer Center.
NCT05837039 is a study of Hypoactive Delirium that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05837039, a study of Hypoactive Delirium, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn about your feelings as a caregiver about the level of discomfort of patients who have hypoactive delirium (loss of contact and response to reality) and who are at the end of life
Primary Outcome
Score Scales: (1-5) 1. Strongly Disagree 2. Disagree 3. Neither Agree Nor Disagree 4. Agree 5. Strongly Agree
Conditions Studied
Interventions
- BEHAVIORAL Healthcare Provider
- BEHAVIORAL Caregiver Perception
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-03-25 |
| Est. Completion | 2027-12-31 |
What NCT05837039 shows while recruiting
NCT05837039 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Hypoactive Delirium appearing as the primary indexed condition, and to 2 interventions - of which Healthcare Provider is the first listed.
NCT05837039 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05837039 about?
NCT05837039 is a clinical study titled "A Comparison of Healthcare Provider and Caregiver Perception of Discomfort in Advanced Cancer Patients Who Have a Hypoactive Delirium". To learn about your feelings as a caregiver about the level of discomfort of patients who have hypoactive delirium (loss of contact and response to reality) and who are at the end of life
What is the current status of trial NCT05837039?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-03-25. Estimated completion is 2027-12-31.
What conditions does trial NCT05837039 study?
This clinical trial studies the following conditions: Hypoactive Delirium.
What interventions are being tested in trial NCT05837039?
The interventions under investigation include: Healthcare Provider (BEHAVIORAL), Caregiver Perception (BEHAVIORAL).
Who is sponsoring clinical trial NCT05837039?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05837039 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI